In all, a higher level of IL-38 in patients suggests that they have better ability to interact with the biochemical pathways involved in inflammation and/or metabolic disease complications, which are indicated by abnormal serum levels of hs-CRP and/or HbA1c. Here, IL1F10 is linked to Other metabolic disease.